文献速递胃肠外科围术期管理与 ERAS

产前miR-200b治疗改善先天性膈疝相关肺发育不良

Prenatal microRNA miR-200b Therapy Improves Nitrofen-induced Pulmonary Hypoplasia Associated With Congenital Diaphragmatic Hernia.
PubMed 文献 · Ann Surg · 2019-01-01

该研究在硝基芬诱导的大鼠模型中评估产前经胎盘miR-200b治疗肺发育不良和先天性膈疝(CDH)的作用。研究发现CDH晚期肺发育不良与miR-200b代偿性上调相关,早期增加miR-200b可降低SMAD驱动的TGF-β信号并在体内外挽救肺发育不良,同时降低CDH发生率。

要点

  • CDH相关肺发育不良中miR-200b呈代偿性上调。
  • 产前miR-200b治疗可改善肺发育不良并降低CDH发生率。
  • miR-200b通过降低SMAD驱动的TGF-β信号发挥作用。

核心结论

  • miR-200b可改善肺发育不良并降低CDH发生率。

研究设计与样本

  • 在硝基芬诱导的肺发育不良和CDH大鼠模型中评估产前经胎盘miR-200b治疗。

主要发现

  • CDH晚期肺发育不良与低发育不良肺中miR-200b的代偿性上调相关。
  • 硝基芬处理后早期用模拟物增加miR-200b可降低SMAD驱动的TGF-β信号。
  • 在体外和体内均挽救肺发育不良,并降低观察到的CDH发生率。

局限性

  • 研究为硝基芬大鼠模型,结论需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to evaluate the use of miR-200b as a prenatal transplacental therapy in the nitrofen rat model of abnormal lung development and congenital diaphragmatic hernia (CDH). BACKGROUND: Pulmonary hypoplasia (PH) and pulmonary hypertension determine mortality and morbidity in CDH babies. There is no safe medical prenatal treatment available. We previously discovered that higher miR-200b is associated with better survival in CDH babies. Here, we investigate the role of miR-200b in the nitrofen rat model of PH and CDH and evaluate its use as an in vivo prenatal therapy. METHODS: We profiled miR-200b expression during nitrofen-induced PH using RT-qPCR and in situ hybridization in the nitrofen rat model of PH and CDH. The effects of nitrofen on downstream miR-200b targets were studied in bronchial lung epithelial cells using a SMAD luciferase assay, Western blotting and Immunohistochemistry. We evaluated miR-200b as a lung growth promoting therapy ex vivo and in vivo using lung explant culture and transplacental prenatal therapy in the nitrofen rat model. RESULTS: We show that late lung hypoplasia in CDH is associated with (compensatory) upregulation of miR-200b in less hypoplastic lungs. Increasing miR-200b abundance with mimics early after nitrofen treatment decreases SMAD-driven TGF-β signaling and rescues lung hypoplasia both in vitro and in vivo. Also, prenatal miR-200b therapy decreases the observed incidence of CDH. CONCLUSIONS: Our data indicate that miR-200b improves PH and decreases the incidence of CDH. Future studies will further exploit this newly discovered prenatal therapy for lung hypoplasia and CDH.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Khoshgoo N, Kholdebarin R, Pereira-Terra P, et al. Prenatal microRNA miR-200b Therapy Improves Nitrofen-induced Pulmonary Hypoplasia Associated With Congenital Diaphragmatic Hernia. Ann Surg. 2019. PMID: 29135495. doi:10.1097/SLA.0000000000002595

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。